Search Within

Neil Jayendra Shah

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Sloan Kettering Institute Postdocs (7)
  4. Solid Tumor Oncology Division (7)
  5. Department of Pathology and Laboratory Medicine (6)
  6. Division of Subspecialty Medicine (4)

More Groups

People
  1. Andrea Knezevic (3)
  2. Andrea Moy (3)
  3. Chung-Han Lee (3)
  4. Darren Feldman (3)
  5. David Aggen (3)
  6. Deaglan McHugh (3)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (2)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancers (1)
  3. Clinical Cancer Research (1)
  4. European Urology Oncology (1)
  5. Journal of Allergy and Clinical Immunology (1)
  6. Journal of Experimental Medicine (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Elsevier BV (1)
  4. MDPI (1)
  5. Mosby Elsevier (1)
  6. Rockefeller University Press (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis
    Journal Article

    Shang, J.; Del Valle, D. M.; Britton, G. J.; Mead, K. R.; Rajpal, U.; Chen-Liaw, A.; Mogno, I.; Li, Z.; Menon, R.; Gonzalez-Kozlova, E.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses
    Meeting Abstract

    Goleva, E.; Lacouture, M.; Lyubchenko, T.; Gu, S.; Xiao, O.; Kraehenbuehl, L.; Berdyshev, E.; Ketosugbo, K.; Moy, A.; Rotemberg, V.; more...
    Journal of Allergy and Clinical Immunology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of talazoparib and avelumab in genomically defined metastatic kidney cancer
    Journal Article

    Kotecha, R. R.; Doshi, S. D.; Knezevic, A.; Chaim, J.; Chen, Y.; Jacobi, R.; Zucker, M.; Reznik, E.; McHugh, D.; Shah, N. J.; more...
    European Urology Oncology (2024)

    Fulltext@MSK | Save
  • Immunologic profiling of immune-related cutaneous adverse events with checkpoint inhibitors reveals polarized actionable pathways
    Journal Article

    Lacouture, M. E.; Goleva, E.; Shah, N.; Rotemberg, V.; Kraehenbuehl, L.; Ketosugbo, K. F.; Merghoub, T.; Maier, T.; Bang, A.; Gu, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Fitzgerald, K. N.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y. B.; Zucker, M.; Lefkowitz, R. A.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase II trial of cabozantinib plus nivolumab in patients with non-clear-cell renal cell carcinoma and genomic correlates
    Journal Article

    Lee, C. H.; Voss, M. H.; Carlo, M. I.; Chen, Y. B.; Zucker, M.; Knezevic, A.; Lefkowitz, R. A.; Shapnik, N.; Dadoun, C.; Reznik, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Contribution of the skin–gut axis to immune-related adverse events with multi-system involvement
    Journal Article

    Kuo, A. M.; Kraehenbuehl, L.; King, S.; Leung, D. Y. M.; Goleva, E.; Moy, A. P.; Lacouture, M. E.; Shah, N. J.; Faleck, D. M.
    Cancers (2022)

    Fulltext@MSK | Save